|
The Journal of Lipid Research, Vol. 40, 1131-1139, June 1999
Copyright © 1999 by Lipid Research, Inc.
The identification of specific high density lipoprotein3 binding sites on human blood monocytes using fluorescence-labeled ligand
Hiroya Hidakaa,
Eiko Hidakaa,
Minoru Tozukaa,
Jun Nakayamaa,
Tsutomu Katsuyamaa, and
Noel Fidgeb
a Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan
b Lipoprotein and Atherosclerosis Unit, Baker Medical Research Institute, Melbourne, Australia
Correspondence to:
Hiroya Hidaka
We previously reported the identity and purification of two HDL3-binding proteins in rat liver plasma membranes. As these proteins are candidate high density lipoprotein (HDL) receptors and probably multifunctional, including a role in HDL metabolism, we have considerable interest in identifying corresponding proteins that are present in human tissue. This report describes the identification of HDL3-binding sites on human monocytes with the use of fluorescence microscopy and flow cytometry assay. After the incubation of mononuclear cells from human blood with fluorescein isothiocyanate (FITC)-labeled human HDL3, fluorescence micrographs showed dense signals of fluorescent grains on monocytes, but not lymphocytes. A significant increase in FITC intensity on monocytes, but not lymphocytes, was observed by flow cytometry analysis, and the interaction between FITC-HDL3 and human monocytes was concentration-dependent. Although very low density (VLDL) and low density lipoprotein (LDL) were ineffective competitors and HDL2 only partially competed for binding, a 50-fold concentration of HDL3 did compete effectively for binding of FITC-HDL3 to human monocytes. Trypsin treatment reduced the FITC intensity of monocytes, showing that a portion of cell-associated FITC-HDL3 remained bound to the cell surface. Two major HDL-binding proteins were identified in CHAPS-solubilized human mononuclear cells by ligand blotting, using HDL3 as the ligand. Both showed similar binding parameters, specificity, and molecular weight identical to HB1 and HB2 from rat liver plasma membrane. We conclude that corresponding candidate HDL receptors or a similar receptor complex also exist on human blood monocytes.Hidaka, H., E. Hidaka, M. Tozuka, J. Nakayama, T. Katsuyama, and N. Fidge. Identification of specific high density lipoprotein3 binding sites on human blood monocytes using fluorescence-labeled ligand. J. Lipid Res. 1999. 40: 11311139.
Supplementary key words:
HDL3, HDL-binding protein, monocyte, flow cytometry, fluorescent isothiocyanate

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Nakabayashi, K. Yamauchi, M. Sugano, K. Sano, M. Tozuka, and H. Hidaka
Degradation of Pre-{beta}-High Density Lipoproteins and Their Binding Activity to Human Blood Monocytes
Ann. Clin. Lab. Sci.,
July 1, 2004;
34(3):
287 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hidaka, M. Tozuka, K. Yamauchi, H. Ohta, J. Nakayama, and T. Katsuyama
Purification and Measurement of HDL3-binding Proteins in Human Peripheral Blood Mononuclear Cells
Ann. Clin. Lab. Sci.,
July 1, 2003;
33(3):
271 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hyka, J.-M. Dayer, C. Modoux, T. Kohno, C. K. Edwards III, P. Roux-Lombard, and D. Burger
Apolipoprotein A-I inhibits the production of interleukin-1{beta} and tumor necrosis factor-{alpha} by blocking contact-mediated activation of monocytes by T lymphocytes
Blood,
April 15, 2001;
97(8):
2381 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|